Texas Biomed now part of global "100 Days Mission" effort aimed at preventing and quickly containing infectious disease outbreaks through accelerated vaccine development SAN ANTONIO , Oct. 28, 2024 /PRNewswire/ -- Texas Biomedical Research Institute (Texas Biomed) has entered a global partnership with the Coalition for Epidemic Preparedness Innovations ( CEPI ). The five-year agreement will see the Institute join CEPI's specialized preclinical network totaling 16 laboratories worldwide.
Under the partnership, Texas Biomed will deliver preclinical research and resources to help develop vaccines for reducing global epidemic and pandemic risks. "This is an exciting moment for Texas Biomed as we take a leading role in the development of viable countermeasures for infectious diseases," said Larry Schlesinger , M.D.
, President/CEO. "This decade has seen a tripling of large outbreaks relative to prior decades and the threat is not going away. Texas Biomed has a vital role to play in addressing this global public health issue and this partnership with CEPI is a major recognition of the quality of our science.
" CEPI was formed in 2017 after the devastating West African Ebola epidemic that killed 11,000 people. The coalition aims to transform the world's response to the next novel threat by supporting researchers and scientists in producing safe and effective vaccines, among other strategies. It has received support from over 30 national governments and key philanthropic organizations,.
